Colchicine for heart disease after stent placement
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older.
- You have coronary artery disease and recently had a stent placed (within 5 days).
- You have at least one other risk factor, such as diabetes, current smoking, high blood pressure, or high cholesterol.
- You do not have serious liver, kidney, or nerve problems.
- You are not pregnant, planning to become pregnant, or father a child during the study.
- You are not already taking colchicine or medications that interact with it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking colchicine can prevent coronary artery disease (heart artery blockages) in people who have several heart risk factors but do not already have diagnosed disease. It aims to see if colchicine lowers the chance of developing heart artery problems over time.
This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.
This trial tests whether adding a targeted anti-inflammatory drug to standard care can prevent future heart attacks or strokes in people with high-risk chronic coronary artery disease. It is for people who have a moderate narrowing in a heart artery with a vulnerable plaque and signs of inflammation.
This trial tests whether the drug colchicine can reduce the chance of developing atrial fibrillation (an irregular heart rhythm) after open-heart surgery. If it works, it could help you recover more smoothly.
This trial tests whether colchicine (a medicine used for gout) can help prevent heart problems after a stent procedure (PCI). It's for people who are in the hospital getting a stent and follow standard heart care.
This study tests if colchicine, a medicine used for gout and inflammation, can help people with coronary heart disease who have had a stent placed. You might be eligible if you have ongoing inflammation (measured by a simple blood test) and are already on standard heart medications.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.